Inhibitors of cytoskeletal function and signal transduction to study bacterial invasion.
Rosenshine
I
I
Department of Biochemistry, University of British Columbia, Vancouver, Canada.
Ruschkowski
S
S
Finlay
B B
BB
D008841:Actin Cytoskeleton / Q000187:drug effects / Q000502:physiology; D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D001419:Bacteria / Q000187:drug effects / Q000254:growth & development / Q000472:pathogenicity*; D002396:Catechols / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology; D003572:Cytochalasins / Q000494:pharmacology; D003599:Cytoskeleton / Q000187:drug effects* / Q000502:physiology; D019833:Genistein; D007529:Isoflavones / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D015739:Nocodazole / Q000494:pharmacology; D047428:Protein Kinase Inhibitors; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology; D019311:Staurosporine; D020032:Tyrphostins; D014747:Vinblastine / Q000494:pharmacology; D014750:Vincristine / Q000494:pharmacology
D000470:Alkaloids; D002396:Catechols; D002614:Chelating Agents; D003572:Cytochalasins; D007529:Isoflavones; D009570:Nitriles; D047428:Protein Kinase Inhibitors; D020032:Tyrphostins; C060152:tyrphostin 47; D014750:Vincristine; D014747:Vinblastine; D019833:Genistein; D019311:Staurosporine; D015739:Nocodazole